Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,483,434
+$471,218 QoQ
Shares Held
9,869
+6.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#1,789
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAMDEN NATIONAL BANK holds $48,743,727 across 8 Drug Manufacturers - General names. ABBV ranks #4 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
69,914 | $17,756,057 | |
| 2 | MRK |
Merck & Co., Inc.
|
113,039 | $14,525,511 | |
| 3 | NVS |
Novartis AG
|
70,745 | $11,087,156 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
9,869 | $2,483,434 | |
| 5 | LLY |
ELI LILLY & Co
|
1,578 | $1,892,700 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,850 | $360,068 | |
| 7 | PFE |
Pfizer Inc
|
14,370 | $346,029 | |
| 8 | AZN |
Astrazeneca PLC
|
1,544 | $292,772 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,483,434 | 9,869 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $2,012,216 | 9,252 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $2,159,458 | 9,451 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $2,183,190 | 9,429 | Shares | Defined | 2025-11-06 | |
| 2025-06-30 | $1,841,164 | 9,919 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,268,891 | 10,829 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,867,448 | 10,509 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,942,412 | 9,836 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,712,798 | 9,986 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,456,982 | 8,001 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $1,276,332 | 8,236 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $1,319,926 | 8,855 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $1,179,426 | 8,754 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $1,438,314 | 9,025 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $1,633,230 | 10,106 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,468,391 | 10,941 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $1,699,463 | 11,096 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $1,857,132 | 11,456 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $1,607,604 | 11,873 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,288,075 | 11,941 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $1,314,621 | 11,671 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $1,240,850 | 11,466 | Shares | Defined | 2021-08-04 | |
| 2020-12-31 | $1,170,506 | 10,924 | Shares | Defined | 2021-02-01 | |
| 2020-09-30 | $935,373 | 10,679 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $977,480 | 9,956 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $751,157 | 9,859 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||